KidneyCancerProgram
@KCPUTSW
Followers
981
Following
842
Media
127
Statuses
796
The Kidney Cancer Program, part of the Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, is a national leader in research and treatment.
Dallas, TX
Joined June 2016
The FDA has approved belzutifan for the treatment of advanced renal cell carcinoma- a first-in-class drug discovered and developed by UTSW researchers over three decades. https://t.co/DrPAWr3olY
@UTSWNews @utswcancer @UTSWInternalMed
utsouthwestern.edu
The U.S. Food & Drug Administration has expanded the approved use of belzutifan for treatment of metastatic kidney cancer, another milestone for the novel, first-in-class kidney cancer drug arising...
0
3
8
🙌 Thank you to @JBrugarolas @KCPUTSW for being the catalyst for this first-ever pre-clinical models workshop! Through collaboration and innovative spirits we continue working to bring better therapies and diagnostics to the #kidneycancer community! #UnstoppableTogether #RCCAMW
0
7
19
Congratulations to @KCPUTSW @UTSWHemeOnc investigators on their @CD_AACR paper https://t.co/iauTEQZM27 establishing a role for #HIF2 in PTHrP regulation and hypercalcemia in #renalcancer & @kaelin_lab in press @NatureMedicine.
aacrjournals.org
Abstract. Renal cell carcinoma (RCC) patients with hypercalcemia (HC) have worse outcomes. HC often involves PTHrP, and the role of HIF-2 is incompletely understood. Leveraging RCC tumorgraft (TG)...
2
6
19
New Cancer Discovery (@CD_AACR) paper from the Brugarolas Lab! Drs. Arijit Mal & Bingqing Xie, with Dr. @JBrugarolas, reveal a strategy to overcome calcium imbalance in kidney cancer. 🔗 https://t.co/0vm1CjSZkX 🔗 https://t.co/xKGdj3hD4d
utsouthwestern.edu
Elevated calcium levels in the blood – a complication of kidney cancers known as hypercalcemia – may be successfully treated with a class of medications called HIF-2 inhibitors developed by UT...
0
2
8
UTSW has now taken a new step with AI, developing a system that extracts crucial info from medical records with 99% accuracy. Significantly speeding up data collection and marking a major way forward for more research. #kidneycancer #UTSW
https://t.co/6YsGayh1LJ
utsouthwestern.edu
A multidisciplinary team at UT Southwestern Medical Center has developed an artificial intelligence (AI)-enabled pipeline that can quickly and accurately extract relevant information from complex,...
0
1
6
Learn more:
utsouthwestern.edu
Scientists have discovered tumors can tap a nontraditional pathway to acquire lipoproteins – molecules that transport fat in blood – which enriches cancer cells with an antioxidant shield to survive...
Scientists at UTSW have discovered that tumors have sugar-coated pathways to grab vitamin E from lipoproteins, allowing for an antioxidant shield that helps cancer survive. Blocking this could help make tumors more vulnerable to treatment. #KidneyCancer #utsw
0
0
2
Scientists at UTSW have discovered that tumors have sugar-coated pathways to grab vitamin E from lipoproteins, allowing for an antioxidant shield that helps cancer survive. Blocking this could help make tumors more vulnerable to treatment. #KidneyCancer #utsw
0
0
1
In partnership with the Kidney Cancer Association, KCP will host a 3-day Kidney Cancer Animal workshop in September. From Thursday, September 11, to Saturday, September 13, 2025 featuring 30 faculty members that will present on Mouse Model topics.
kcp.utsw.edu
1
0
1
How do cancer cells escape death? Dr. Garcia-Bermudez (@JaviGBermudez) and his team found they hijack fat molecules to shield themselves. Featured in @dallasnews + @Nature, this discovery could open new doors for cancer therapy. #utsw #kidneycancer
UT Southwestern researchers find cancer’s secret weapon to defeat death
0
1
2
A study co-led by @bsabari found that a gene fusion drives rare kidney cancer (tRCC) by forming protein clusters that disrupt gene activity. This may also occur in other cancers, revealing a potential new target for future therapies. #KidneyCancer #utsw
https://t.co/KrjLyDqpGt
utsouthwestern.edu
A genetic mutation that fuses two genes drives several different cancer types by forming networks of protein interactions that alter gene expression in cells, a study by UT Southwestern Medical...
0
2
11
Drs. Rajaram and @PayalKapur5 of the Kidney Cancer Program, co-led a groundbreaking @NatureComms study using AI to predict which patients with clear-cell kidney cancer will benefit from anti-angiogenic therapy. A major step toward more accessible precision medicine!👏
Congratulations to Satwik Rajaram @PayalKapur5 on @NatureComms report https://t.co/Xv1iCX5bnm of a DL AI tool to evaluate angiogenesis in #RCC @KCPUTSW @utswcancer @utswpath
https://t.co/hSiLBIYU4d
0
1
6
🧬Dr. Brugarolas recently spoke with @GUOncologyNow, reflecting on the path to FDA-approved HIF-2 inhibitors and the future of personalized therapy, immunotherapy, and genetic medicine in kidney cancer. #UTSW #kidneycancer #research
https://t.co/dieJMK3KBT
guoncologynow.com
Dr. Brugarolas reflects on his lab's role in developing HIF-2 inhibitors and his ongoing work to improve patient outcomes.
0
2
8
March 30th was #NationalDoctorsDay! We echo Dr. Podolsky: ‘Your ability to listen, empathize, and guide patients with expertise through... difficult and joyful moments epitomizes our values and mission.’ We are grateful for our physicians' compassion, dedication, & impact! #UTSW
0
0
1
Exciting news! 🎉 Three #UTSW researchers received the DoD #KCRP Postdoctoral & Clinical Fellowship Awards! Dr. Jun Fang (@QingZhangLab), Dr. Arijit Mal (@JBrugarolas Lab), & Dr. Dylan Wang (@QingZhangLab) 👏Congrats to all! Read more: https://t.co/XDvpmeADTR
#kidneycancer
3
3
23
Learn how kidney cancer fuels its spread in this Science in 60+ video featuring Dr. DeBerardinis. UTSW researchers found that while primary kidney tumors behave one way, metastatic ones rely on mitochondria for energy. #kidneycancer #utsw #research
utsouthwestern.edu
UT Southwestern research reveals new information about how metastatic kidney cancers get their fuel that could help in development of future therapies.
0
0
3
Celebrating success! 🎉 Our Kidney Cancer SPORE Year 8 DRP & CEP awardees and colleagues came together for a fun pizza gathering to mark their incredible achievements. 🍕 We're proud to support these talented individuals who are making strides in kidney cancer research!
Eight distinguished awardees will be supported as part of Kidney Cancer SPORE Year 8 Developmental Research & Career Enhancement Programs (DRP & CRP). Congratulations, this is well deserved!👏 ##utsw #kidneycancer
0
2
10
Dr. Ralph DeBerardinis received the Core Facility Award, enabling his team to expand tools for assessing metabolism in kidney cancer and other tumors, with the goal of identifying and targeting metabolic weaknesses to improve cancer treatment. Congrats, @RJDLab!
We’re thrilled to announce that several UTSW researchers have been awarded CPRIT grants for their work in kidney cancer research! Stay tuned as we spotlight some of these awardees and their projects over the next few days.
2
2
33
Today we highlight Dr. Kevin Courtney, who received the Clinical Investigator Award. This award will support his clinical research in genitourinary oncology, mentoring of junior faculty, and studies on kidney cancer metabolism. Congrats!
We’re thrilled to announce that several UTSW researchers have been awarded CPRIT grants for their work in kidney cancer research! Stay tuned as we spotlight some of these awardees and their projects over the next few days.
0
0
7
We’re thrilled to announce that several UTSW researchers have been awarded CPRIT grants for their work in kidney cancer research! Stay tuned as we spotlight some of these awardees and their projects over the next few days.
kcp.utsw.edu
1
0
3